Earnings

Tenet Healthcare Soars on Strong Q4, Upbeat 2026 Profit Forecast

Tenet Healthcare shares surged 16% after posting robust fourth-quarter earnings and raising its 2026 adjusted EBITDA outlook to $4.485–$4.785 billion. The company flagged a potential $250 million headwind from expiring ACA subsidies.

James Calloway · · · 3 min read · 365 views
Tenet Healthcare Soars on Strong Q4, Upbeat 2026 Profit Forecast
Mentioned in this article
HCA $473.24 +1.16% THC $188.71 +0.38% UHS $178.97 -1.72% XLV $151.01 +0.81%

Shares of Tenet Healthcare Corporation (THC) experienced a significant rally on Wednesday, February 11, 2026, climbing approximately 16% during the regular trading session. The stock closed at $224.03, representing a gain of $31.00, after trading within a range of $186.79 to $228.82. This surge followed the release of the company's fourth-quarter financial results and an updated long-term profit outlook for the year 2026.

Strong Quarterly Performance and Upbeat Guidance

The hospital operator reported robust financials for the final quarter of the previous year. Net income available to common shareholders reached $371 million, or $4.22 per diluted share, an increase from $318 million in the same period a year earlier. This was achieved on net operating revenues of $5.527 billion. A key profitability metric, Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), rose to $1.183 billion. Similarly, adjusted diluted earnings per share came in at $4.70 for the quarter.

Looking ahead, management provided an optimistic forecast for 2026. The company anticipates Adjusted EBITDA to be in the range of $4.485 billion to $4.785 billion. Adjusted earnings per share are projected to fall between $16.19 and $18.47. CEO Saum Sutaria attributed this positive outlook to sustained demand for the company's acute care and ambulatory surgical services across its markets.

Potential Headwinds from Policy Changes

Despite the bullish guidance, executives highlighted a notable risk factor. During the earnings conference call, Chief Financial Officer Sun Park cautioned that the expiration of enhanced tax credits related to the Affordable Care Act (ACA) exchange plans is expected to negatively impact the business. He estimated this policy change could reduce 2026 Adjusted EBITDA by approximately $250 million, with the majority of the effect concentrated in Tenet's hospital segment. Park noted that in the fourth quarter, exchange plans accounted for roughly 7.5% of hospital admissions and just over 6.5% of the company's consolidated revenue. The expiration is projected to lead to lower volume growth and a less favorable payer mix as some patients may lose subsidized coverage.

The broader hospital sector also saw positive momentum on the trading day. Peer company HCA Healthcare (HCA) advanced about 5.9%, while Universal Health Services (UHS) gained approximately 8.6%. The Health Care Select Sector SPDR Fund (XLV), a key sector ETF, moved up around 0.5%.

Market Context and Future Checkpoints

Tenet's performance and guidance are being closely watched as a barometer for the broader hospital industry, which faces a dynamic environment of shifting insurance coverage and variable government reimbursement rates. Investors are particularly focused on whether recent margin improvements can be maintained amid potential changes in patient demographics and persistent wage inflation pressures. Tenet, with its portfolio of acute-care hospitals and a substantial outpatient surgery business through USPI, is seen as a key indicator for procedural demand and the financial mix between commercial insurance, government programs, and self-pay patients.

The wide range in the company's 2026 outlook underscores the inherent uncertainties. If enrollment in ACA exchange plans declines more sharply than anticipated, or if supplemental Medicaid payments face political or budgetary pressure, Tenet could encounter a more challenging patient mix and compressed profit margins. The upcoming quarter ending March 31, 2026, will serve as an important early indicator. Analysts and investors will scrutinize this period for initial signs regarding exchange plan volumes and any potential revisions to the company's underlying assumptions. The primary focus will then shift to assessing Tenet's ability to execute and deliver results near the upper end of its ambitious 2026 profit targets.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →